{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T21:09:02Z","timestamp":1790024942793,"version":"4.0.1"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003141","name":"Consejo Nacional de Ciencia y Tecnolog\u00eda","doi-asserted-by":"publisher","award":["2013-1-201874"],"award-info":[{"award-number":["2013-1-201874"]}],"id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Gerontology"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.exger.2019.05.013","type":"journal-article","created":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T02:44:02Z","timestamp":1559097842000},"page":"110624","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Monocyte chemoattractant protein-1 (MCP-1) and fibroblast growth factor-21 (FGF-21) as biomarkers of subclinical atherosclerosis in women"],"prefix":"10.1016","volume":"124","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2991-0433","authenticated-orcid":false,"given":"Lourdes","family":"Basurto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8138-3151","authenticated-orcid":false,"given":"Michael A.","family":"Gregory","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana Barrera","family":"Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucero","family":"S\u00e1nchez-Huerta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alma D\u00edaz","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leticia","family":"Manuel-Apolinar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco J.","family":"Avelar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura Alejandra Mej\u00eda","family":"Alonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2043-9363","authenticated-orcid":false,"given":"Rosalinda","family":"S\u00e1nchez-Arenas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exger.2019.05.013_bb0005","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.diabres.2012.01.004","article-title":"Serum fibroblast growth factor 21 was elevated in subjects with type 2 diabetes mellitus and was associated with the presence of carotid artery plaques","volume":"96","author":"An","year":"2012","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"3","key":"10.1016\/j.exger.2019.05.013_bb0010","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1155\/MI.2005.175","article-title":"Serum levels of the MCP-1 chemokine in patients with ischemic stroke and myocardial infarction","author":"Arakelyan","year":"2005","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.exger.2019.05.013_bb0015","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.molmet.2015.04.002","article-title":"Fibroblast growth factor 21 is elevated in metabolically unhealthy obesity and affects lipid deposition, adipogenesis, and adipokine secretion of human abdominal subcutaneous adipocytes","volume":"4","author":"Berti","year":"2015","journal-title":"Molecular Metabolism"},{"key":"10.1016\/j.exger.2019.05.013_bb0020","doi-asserted-by":"crossref","first-page":"3652","DOI":"10.1073\/pnas.91.9.3652","article-title":"Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant","volume":"91","author":"Carr","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.exger.2019.05.013_bb0025","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1161\/ATVBAHA.113.301599","article-title":"Serum fibroblast growth factor-21 levels are associated with carotid atherosclerosis independent of established cardiovascular risk factors","volume":"33","author":"Chow","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.exger.2019.05.013_bb0030","first-page":"122","article-title":"Menopausal women have hypofibrinolysis even in subclinical stage of atherosclerosis","volume":"67","author":"C\u00f3rdova-P\u00e9rez","year":"2015","journal-title":"Rev. Investig. Clin."},{"key":"10.1016\/j.exger.2019.05.013_bb0035","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0021-9150(98)00318-9","article-title":"Absence of CC chemokine receptor-2 reduces atherosclerosis in apolipoprotein E-deficient mice","volume":"143","author":"Dawson","year":"1999","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.exger.2019.05.013_bb0040","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1161\/01.CIR.0000049742.68848.99","article-title":"Association between plasma levels of monocyte chemoattractant protein-1 and long-term clinical outcomes in patients with acute coronary syndromes","volume":"107","author":"de Lemos","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.exger.2019.05.013_bb0045","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1016\/j.jacc.2004.07.047","article-title":"Association among plasma levels of monocyte chemoattractant protein-1, traditional cardiovascular risk factors, and subclinical atherosclerosis","volume":"44","author":"Deo","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.exger.2019.05.013_bb0050","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1089\/jir.2008.0027","article-title":"Monocyte chemoattractant protein-1 (MCP-1): an overview","volume":"29","author":"Deshmane","year":"2009","journal-title":"J. Interf. Cytokine Res."},{"key":"10.1016\/j.exger.2019.05.013_bb0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.33549\/physiolres.931610","article-title":"Fibroblast growth factor 21: a novel metabolic regulator with potential therapeutic properties in obesity\/type 2 diabetes mellitus","volume":"58","author":"Dost\u00e1lov\u00e1","year":"2009","journal-title":"Physiol. Res."},{"key":"10.1016\/j.exger.2019.05.013_bb0060","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1475-2840-8-52","article-title":"Prevalence of the metabolic syndrome in Latin America and its association with sub-clinical carotid atherosclerosis: the CARMELA cross sectional study","volume":"8","author":"Escobedo","year":"2009","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.exger.2019.05.013_bb0065","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.recesp.2013.10.013","article-title":"Epicardial adipose tissue is associated with visceral fat, metabolic syndrome, and insulin resistance in menopausal women","volume":"67","author":"Fern\u00e1ndez Mu\u00f1oz","year":"2014","journal-title":"Rev. Esp. Cardiol. (Engl Ed)."},{"key":"10.1016\/j.exger.2019.05.013_bb0075","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13293-017-0152-8","article-title":"The protective role of estrogen and estrogen receptors in cardiovascular disease and the controversial use of estrogen therapy","volume":"8","author":"Iorga","year":"2017","journal-title":"Biol. Sex Differ."},{"key":"10.1016\/j.exger.2019.05.013_bb0080","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ypmed.2016.05.009","article-title":"Prevalence and trends in physical activity among older adults in the United States: a comparison across three national surveys","volume":"89","author":"Keadle","year":"2016","journal-title":"Prev. Med."},{"key":"10.1016\/j.exger.2019.05.013_bb0085","series-title":"The Role of Fibroblast Growth Factor 21 in Atherosclerosis","first-page":"259","volume":"257","author":"Kokkinos","year":"2017"},{"key":"10.1016\/j.exger.2019.05.013_bb0090","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/MCO.0b013e328346a326","article-title":"Fibroblast growth factor 21: effects on carbohydrate and lipid metabolism in health and disease","volume":"14","author":"Kralisch","year":"2011","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"10.1016\/j.exger.2019.05.013_bb0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1005553","article-title":"Metabolomic quantitative trait loci (mQTL) mapping implicates the ubiquitin proteasome system in cardiovascular disease pathogenesis","volume":"11","author":"Kraus","year":"2015","journal-title":"PLoS Genet."},{"key":"10.1016\/j.exger.2019.05.013_bb0100","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1089\/107999099314234","article-title":"Human endothelium as a source of multifunctional cytokines: molecular regulation and possible role in human disease","volume":"19","author":"Krishnaswamy","year":"1999","journal-title":"J. Interf. Cytokine Res."},{"key":"10.1016\/j.exger.2019.05.013_bb0105","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1161\/01.CIR.95.3.693","article-title":"Induction of monocyte chemoattractant protein-1 in the small veins of the ischemic and reperfused canine myocardium","volume":"95","author":"Kumar","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.exger.2019.05.013_bb0110","doi-asserted-by":"crossref","first-page":"11","DOI":"10.14366\/usg.13018","article-title":"General principles of carotid Doppler ultrasonography","volume":"33","author":"Lee","year":"2014","journal-title":"Ultrasonography"},{"key":"10.1016\/j.exger.2019.05.013_bb0115","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/cen.12134","article-title":"Serum FGF21 concentration is associated with hypertriglyceridaemia, hyperinsulinaemia and pericardial fat accumulation, independently of obesity, but not with current coronary artery status","volume":"80","author":"Lee","year":"2014","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.exger.2019.05.013_bb0120","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1210\/jc.2008-2331","article-title":"Serum fibroblast growth factor 21 is associated with adverse lipid profiles and gamma-glutamyltransferase but not insulin sensitivity in Chinese subjects","volume":"94","author":"Li","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.exger.2019.05.013_bb0125","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1161\/01.CIR.91.11.2844","article-title":"Molecular bases of the acute coronary syndromes","volume":"91","author":"Libby","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.exger.2019.05.013_bb0130","doi-asserted-by":"crossref","first-page":"4580","DOI":"10.2174\/1381612820666140522115801","article-title":"Impact of MCP1 in atherosclerosis","volume":"20","author":"Lin","year":"2014","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.exger.2019.05.013_bb0135","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1161\/CIRCULATIONAHA.115.015308","article-title":"Fibroblast growth factor 21 prevents atherosclerosis by suppression of hepatic sterol regulatory element-binding protein-2 and induction of adiponectin in mice","volume":"131","author":"Lin","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.exger.2019.05.013_bb0145","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jacl.2008.02.006","article-title":"Coronary heart disease risk factors and atherosclerosis in young people","volume":"2","author":"McMahan","year":"2008","journal-title":"J. Clin. Lipidol."},{"key":"10.1016\/j.exger.2019.05.013_bb0150","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1161\/01.CIR.90.2.775","article-title":"Macrophage infiltration in acute coronary syndromes. Implications for plaque rupture","volume":"90","author":"Moreno","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.exger.2019.05.013_bb0155","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1161\/CIRCULATIONAHA.110.968792","article-title":"Sex\/gender differences in cardiovascular disease prevention: what a difference a decade makes","volume":"124","author":"Mosca","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.exger.2019.05.013_bb0160","author":"National Institute of Statistics and Geography (NIOSA)"},{"key":"10.1016\/j.exger.2019.05.013_bb0165","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0167-4781(00)00067-1","article-title":"Identification of a novel FGF, FGF-21, preferentially expressed in the liver","volume":"1492","author":"Nishimura","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.exger.2019.05.013_bb0170","first-page":"219","article-title":"Evaluation of total adiponectin, adipocyte fatty acid binding protein and fibroblast growth factor 21 levels in individuals with metabolic syndrome","volume":"63","author":"Novotny","year":"2014"},{"key":"10.1016\/j.exger.2019.05.013_bb0175","first-page":"153","article-title":"Imaging atherosclerosis by carotid intima-media thickness in vivo: how to, where and in whom","volume":"7","author":"Onut","year":"2012","journal-title":"Maedica (Buchar)"},{"key":"10.1016\/j.exger.2019.05.013_bb0180","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3389\/fendo.2015.00133","article-title":"FGF21 and cardiac physiopathology","volume":"6","author":"Planavila","year":"2015","journal-title":"Front. Endocrinol. (Lausanne)."},{"key":"10.1016\/j.exger.2019.05.013_bb0185","doi-asserted-by":"crossref","DOI":"10.1186\/s12947-015-0041-4","article-title":"Causes of changes in carotid intima-media thickness: a literature review","volume":"13","author":"Qu","year":"2015","journal-title":"Cardiovasc. Ultrasound"},{"key":"10.1016\/j.exger.2019.05.013_bb0190","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.numecd.2007.03.008","article-title":"Endothelial function and arterial stiffness in normotensive normoglycemic first-degree relatives of diabetic patients are independent of the metabolic syndrome","volume":"18","author":"Scuteri","year":"2008","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"10.1016\/j.exger.2019.05.013_bb0195","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1152\/japplphysiol.90553.2008","article-title":"Habitual exercise and arterial aging","volume":"105","author":"Seals","year":"2008","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.exger.2019.05.013_bb0205","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/1475-2840-12-124","article-title":"Additive relationship between serum fibroblast growth factor 21 level and coronary artery disease","volume":"12","author":"Shen","year":"2013","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.exger.2019.05.013_bb0210","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1161\/ATVBAHA.109.196980","article-title":"The value of carotid intima-media thickness for predicting cardiovascular risk","volume":"30","author":"Simon","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.exger.2019.05.013_bb0215","author":"The World Health Organization"},{"key":"10.1016\/j.exger.2019.05.013_bb0220","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1159\/000343145","volume":"34","author":"Touboul","year":"2012","journal-title":"Cerebrovasc. Dis."},{"key":"10.1016\/j.exger.2019.05.013_bb0225","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/cen.12095","article-title":"Fibroblast growth factor 21 as an emerging metabolic regulator: clinical perspectives","volume":"78","author":"Woo","year":"2013","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.exger.2019.05.013_bb0230","doi-asserted-by":"crossref","DOI":"10.1186\/s12933-015-0229-9","article-title":"Serum fibroblast growth factor 21 levels are related to subclinical atherosclerosis in patients with type 2 diabetes","volume":"14","author":"Xiao","year":"2015","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.exger.2019.05.013_bb0235","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.dsx.2018.12.007","article-title":"Fibroblast growth factor 21 association with subclinical atherosclerosis and arterial stiffness in type 2 diabetes","volume":"13","author":"Yafei","year":"2019","journal-title":"Diabetes Metab. Syndr. Clin. Res. Rev."},{"issue":"6","key":"10.1016\/j.exger.2019.05.013_bb9000","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s11883-015-0509-6","article-title":"Fibroblast growth factor signaling in the vasculature","volume":"17","author":"Yang","year":"2015","journal-title":"Curr. Atheroscler. Rep."}],"container-title":["Experimental Gerontology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0531556518307277?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0531556518307277?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,9,18]],"date-time":"2022-09-18T16:03:37Z","timestamp":1663517017000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0531556518307277"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":45,"alternative-id":["S0531556518307277"],"URL":"https:\/\/doi.org\/10.1016\/j.exger.2019.05.013","relation":{},"ISSN":["0531-5565"],"issn-type":[{"value":"0531-5565","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Monocyte chemoattractant protein-1 (MCP-1) and fibroblast growth factor-21 (FGF-21) as biomarkers of subclinical atherosclerosis in women","name":"articletitle","label":"Article Title"},{"value":"Experimental Gerontology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exger.2019.05.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110624"}}